https://biotechmorning.com/news/perfuze-stroke-catheter-marrs-trial-results Biotech Morning en 2026-08-31T14:14:20.863Z The Stroke Catheter That Barely Needs a Second Try https://biotechmorning.com/news/genentech-hanmi-hm17321-obesity-deal Biotech Morning en 2026-08-31T14:13:38.932Z Genentech Just Paid $2.3B for a Drug That Builds Muscle While You Lose Weight https://biotechmorning.com/news/sarepta-gene-therapy-black-box-warning-layoffs Biotech Morning en 2026-08-31T14:12:50.666Z Sarepta's Gene Therapy Just Got the Scariest Label in Medicine https://biotechmorning.com/news/claude-ai-designed-protein-binders-validated Biotech Morning en 2026-08-31T14:12:06.689Z Claude Just Designed 1,320 Proteins. Most of Them Actually Worked. https://biotechmorning.com/news/lilly-merida-autoantibody-degradation-deal Biotech Morning en 2026-08-31T14:11:19.720Z Lilly Just Spent $2.88 Billion to Teach Your Body to Eat Its Own Antibodies https://biotechmorning.com/news/first-new-et-treatment-30-years-besremi Biotech Morning en 2026-08-31T14:10:31.378Z The First New Blood Cancer Drug in 30 Years Just Got the Green Light https://biotechmorning.com/news/ascendis-biomarin-yuviwel-patent-settlement Biotech Morning en 2026-08-31T14:09:48.857Z The $2 Billion Handshake That Ends Biotech's Nastiest Patent Fight https://biotechmorning.com/news/tenax-tnx-103-level-trial-subgroup-esc-2026 Biotech Morning en 2026-08-30T14:13:24.989Z Tenax's Big Bet Walked 3.5 Meters. Then It Got Interesting. https://biotechmorning.com/news/gene-therapy-biggest-swing-heart-failure Biotech Morning en 2026-08-30T14:12:40.558Z Gene Therapy Just Took Its Biggest Swing at Heart Failure https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-elevidys-3 Biotech Morning en 2026-08-30T14:11:51.086Z Sarepta's Worst Week: A Black Box, 500 Pink Slips, and a $900M Drug in Trouble https://biotechmorning.com/news/ausperbio-120m-series-c-hepatitis-b-cure Biotech Morning en 2026-08-30T14:11:03.552Z Someone Thinks Hepatitis B Can Finally Be Cured https://biotechmorning.com/news/teva-bioxcel-bankruptcy-cns-deal Biotech Morning en 2026-08-30T14:10:16.664Z Teva Goes Dumpster Diving for a $145M Brain Drug https://biotechmorning.com/news/roivant-first-pill-dermatomyositis-fda-approval Biotech Morning en 2026-08-30T14:09:29.511Z The First Pill for a Disease That Eats Your Muscles and Skin https://biotechmorning.com/news/camzyos-five-year-data-esc-2026 Biotech Morning en 2026-08-30T14:08:46.549Z Five Years on One Heart Drug. Here's What Happened. https://biotechmorning.com/news/bayer-evuzamitide-cardiac-amyloidosis-pet-diagnostic Biotech Morning en 2026-08-30T14:07:59.784Z Bayer Just Found a Way to Photograph Your Heart's Worst Secret https://biotechmorning.com/news/stargardt-disease-first-treatment-tinlarebant-2 Biotech Morning en 2026-08-30T14:07:10.252Z The Eye Disease With Zero Treatments Just Got Its First Real Shot